Search by Drug Name or NDC
NDC 00904-6761-30 nasal decongestant 0.05 g/100mL Details
nasal decongestant 0.05 g/100mL
nasal decongestant is a NASAL SPRAY in the HUMAN OTC DRUG category. It is labeled and distributed by Major Pharmaceuticals. The primary component is OXYMETAZOLINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Oxymetazoline nasal spray is used to relieve nasal discomfort caused by colds, allergies, and hay fever. It is also used to relieve sinus congestion and pressure. Oxymetazoline nasal spray should not be used to treat children younger than 6 years of age unless it is recommended by a doctor. Children 6 to 12 years of age should use oxymetazoline nasal spray carefully and under adult supervision. Oxymetazoline is in a class of medications called nasal decongestants. It works by narrowing the blood vessels in the nasal passages.
Related Packages: 00904-6761-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Oxymetazoline Nasal Spray
Product Information
| NDC | 00904-6761 |
|---|---|
| Product ID | 0904-6761_30ac6c99-1384-49e2-84d1-8e52757568a4 |
| Associated GPIs | 42102040102010 |
| GCN Sequence Number | 008039 |
| GCN Sequence Number Description | oxymetazoline HCl SPRAY 0.05 % NASAL |
| HIC3 | Q7D |
| HIC3 Description | NOSE PREPARATIONS, VASOCONSTRICTORS(OTC) |
| GCN | 34062 |
| HICL Sequence Number | 003417 |
| HICL Sequence Number Description | OXYMETAZOLINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | nasal decongestant |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Oxymetazoline HCl |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SPRAY |
| Route | NASAL |
| Active Ingredient Strength | 0.05 |
| Active Ingredient Units | g/100mL |
| Substance Name | OXYMETAZOLINE HYDROCHLORIDE |
| Labeler Name | Major Pharmaceuticals |
| Pharmaceutical Class | Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
Package Images
NDC 00904-6761-30 (00904676130)
| NDC Package Code | 0904-6761-30 |
|---|---|
| Billing NDC | 00904676130 |
| Package | 1 BOTTLE, SPRAY in 1 CARTON (0904-6761-30) / 30 mL in 1 BOTTLE, SPRAY |
| Marketing Start Date | 2018-10-12 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.07251 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | NASAL DECONGESTANT 0.05% SPRAY |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
Standard Product Labeling (SPL)/Prescribing Information SPL 72b91ce9-6394-4098-90e9-1aba1480cacb Details
Uses
Ask a doctor before use if you have
When using this product
- •
- do not use more than directed
- •
- do not use for more than 3 days. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen.
- •
- temporary discomfort such as burning, stinging, sneezing or an increase in nasal discharge may occur
- •
- use of this container by more than one person may spread infection
Keep out of reach of children.
Directions
- •
- adults and children 6 to under 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period.
- •
- children under 6 years of age: ask a doctor
To Use: Shake well before use. Hold white tabs, SQUEEZE grooved area of cap FIRMLY and turn counter clockwise. Before using the first time, prime metered pump by depressing pump firmly several times. To spray, hold bottle with thumb at base and nozzle between first and second fingers. Without tilting head, insert nozzle into nostril. Fully depress rim with a firm, even stroke and sniff deeply. Wipe nozzle clean after use. Secure cap after use.
Other information
Inactive ingredients
Principal Display Panel
INGREDIENTS AND APPEARANCE
| NASAL DECONGESTANT
oxymetazoline hcl spray |
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
| Labeler - Major Pharmaceuticals (191427277) |